Please use this identifier to cite or link to this item: http://bura.brunel.ac.uk/handle/2438/20832
Full metadata record
DC FieldValueLanguage
dc.contributor.authorGhebrehiwet, , B-
dc.contributor.authorKishore, U-
dc.contributor.editorKishore, U-
dc.contributor.editorGhebrehewit, B-
dc.date.accessioned2020-05-13T15:28:34Z-
dc.date.available2020-05-12-
dc.date.available2020-05-13T15:28:34Z-
dc.date.issued2020-05-12-
dc.identifierhttps://www.frontiersin.org/research-topics/5778/c1q-a-molecular-bridge-to-innate-and-adaptive-immunity-
dc.identifier.citation2020, pp. 1 - 92 (92)en_US
dc.identifier.isbn9782889637065-
dc.identifier.issn1664-8714-
dc.identifier.urihttp://bura.brunel.ac.uk/handle/2438/20832-
dc.description.abstractLike in most fields in science, the complement system is also in a fast gear of self-evolution, with new discoveries of unanticipated pathways and functions capable of cross-talk with other biologic systems. An emerging area that has been gaining much attention recently is the role of locally synthesized complement proteins, which mediate a plethora of cellular functions thereby enhancing either health or disease. Prominent among the locally synthesized proteins is C1q, the first subcomponent of the complement classical pathway, which has been shown to regulate a wide range of immunological and pathological processes in autocrine or paracrine manners. Although the main source of the local synthesis of C1q has been attributed to the potent antigen presenting cells such as macrophages and dendritic cells, where it plays as a powerful molecular sensor of danger and regulator of self-tolerance, the list of the type of cells that locally synthesize C1q has been expanding over the years and now includes various types of proliferating and non-proliferating cells including malignant cells. The aim of the current “Frontiers Topic” is, therefore, to compile a comprehensive list of review and research articles by experts in the field, so that they can be a major source of information for researchers and clinicians alike.en_US
dc.description.sponsorshipThis work is supported by a Singapore National University Health System seed fund (R-182-000229-750), a Singapore Ministry of Education Tier 2 grant (MOE2012-T2-2-122), and a Singapore National Medical Research Council Open-funding Individual Research Grant (NMRC/OFIRG/0013/2016).en_US
dc.format.extent10-
dc.format.extent1 - 92 (92)-
dc.languageEnglish-
dc.language.isoenen_US
dc.publisherFrontiers Media SAen_US
dc.subjectImmunologyen_US
dc.subjectcomplement systemen_US
dc.subjectclassical pathwayen_US
dc.subjectC1qen_US
dc.subjectinnate immunityen_US
dc.subjectadaptive immunityen_US
dc.titleC1q: A Molecular Bridge to Innate and Adaptive Immunityen_US
dc.typeBooken_US
dc.identifier.doihttp://dx.doi.org/10.3389/978-2-88963-706-5-
pubs.place-of-publicationLausanne:-
pubs.publication-statusPublished-
Appears in Collections:Dept of Life Sciences Research Papers

Files in This Item:
File Description SizeFormat 
FullText.pdf16.95 MBAdobe PDFView/Open


Items in BURA are protected by copyright, with all rights reserved, unless otherwise indicated.